DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+6.14%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$197M
AUM Growth
+$197M
(+5.2%)
Cap. Flow
+$1.46M
Cap. Flow
% of AUM
0.74%
Top 10 Holdings %
Top 10 Hldgs %
48.07%
Holding
98
New
12
Increased
18
Reduced
28
Closed
7
Top Buys
| 1 |
General Motors
GM
|
$2.59M |
| 2 |
Verizon
VZ
|
$2.49M |
| 3 |
AbbVie
ABBV
|
$2.27M |
| 4 |
CVS Health
CVS
|
$1.62M |
| 5 |
Prothena Corp
PRTA
|
$1.15M |
Top Sells
| 1 |
SPDR Gold Trust
GLD
|
$2.96M |
| 2 |
Intel
INTC
|
$2.44M |
| 3 |
XLNX
Xilinx Inc
XLNX
|
$1.67M |
| 4 |
Gilead Sciences
GILD
|
$1.66M |
| 5 |
Teradata
TDC
|
$1.35M |
Sector Composition
| 1 | Healthcare | 41.17% |
| 2 | Technology | 17.46% |
| 3 | Communication Services | 11.33% |
| 4 | Financials | 6.23% |
| 5 | Consumer Discretionary | 5.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $14.4M | 6.26% | 424,500 | – | – |
|
2
Micron Technology
MU
$133B
| $14.1M | 6.14% | 160,000 | – | – |
|
3
Alphabet (Google) Class C
GOOG
$2.58T
| $13.4M | 5.84% | 6,500 -250 | -4% | -$517K |
|
|
4
AbbVie
ABBV
$372B
| $11M | 4.8% | 102,000 +21,000 | +26% | +$2.27M |
|
5
Xencor
XNCR
$580M
| $8.18M | 3.56% | 190,000 -9,750 | -5% | -$420K |
|
6
Oracle
ORCL
$635B
| $7.37M | 3.2% | 105,000 +13,000 | +14% | +$912K |
|
|
7
SPDR Gold Trust
GLD
$107B
| $6.8M | 2.95% | 42,500 -18,500 | -30% | -$2.96M |
|
8
argenx
ARGX
$43.6B
| $6.61M | 2.87% | 24,000 | – | – |
|
9
Regeneron Pharmaceuticals
REGN
$61.5B
| $6.39M | 2.78% | 13,500 +1,100 | +9% | +$520K |
|
10
Turning Point Brands
TPB
$1.79B
| $6.38M | 2.77% | 122,250 -2,500 | -2% | -$130K |
|
11
Bank of America
BAC
$376B
| $5.8M | 2.52% | 150,000 -17,500 | -10% | -$677K |
|
|
12
General Motors
GM
$55.8B
| $5.75M | 2.5% | 100,000 +45,000 | +82% | +$2.59M |
|
13
Incyte
INCY
$16.5B
| $5.28M | 2.3% | 65,000 +2,500 | +4% | +$203K |
|
|
14
Verizon
VZ
$186B
| $5.09M | 2.21% | 87,500 +42,750 | +96% | +$2.49M |
|
15
Citigroup
C
$178B
| $4.73M | 2.06% | 65,000 -5,000 | -7% | -$364K |
|
16
Advanced Micro Devices
AMD
$264B
| $4.32M | 1.88% | 55,000 | – | – |
|
17
VanEck Gold Miners ETF
GDX
$19B
| $4.14M | 1.8% | 127,500 +7,500 | +6% | +$244K |
|
18
AT&T
T
$209B
| $3.78M | 1.64% | 125,000 -10,000 | -7% | -$303K |
|
19
iShares Gold Trust
IAU
$50.6B
| $3.25M | 1.41% | 200,000 | – | – |
|
20
Alnylam Pharmaceuticals
ALNY
$58.5B
| $2.82M | 1.23% | 20,000 | – | – |
|
21
Amgen
AMGN
$155B
| $2.8M | 1.22% | 11,250 | – | – |
|
|
AOD
22
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.69M | 1.17% | 282,505 -3,912 | -1% | -$37.3K |
|
23
VanEck Junior Gold Miners ETF
GDXJ
$6.6B
| $2.59M | 1.12% | 57,500 | – | – |
|
24
Bristol-Myers Squibb
BMY
$96B
| $2.53M | 1.1% | 40,000 | – | – |
|
25
Eli Lilly
LLY
$657B
| $2.1M | 0.91% | 11,250 +5,250 | +88% | +$981K |
|